The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 84, Issue 2, 2012, Pages 86-92

  Knychalski, Bartłomiej ^a   Łukieńczuk, Tadeusz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

CCSA 2; CEA; colorectal cancer; tumor biomarkers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COLON CANCER SPECIFIC ANTIGEN 2, HUMAN; COLON CANCER-SPECIFIC ANTIGEN 2, HUMAN; NUCLEAR PROTEIN; TUMOR ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CANCER STAGING; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; AREA UNDER CURVE; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84859608333     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-012-0014-3     Document Type: Article

References (16)

1. Steward BW, Kleihues P: World cancer report. IARC Press, Lyon, France 2003: 198.
2. Al-Mulla F, Behbehani AI, Bitar MS et al.: Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse. Mod Pathol 2006; 19: 648-58.
3. Wojciechowska U, Didkowska J, Zatõski W: Nowotwory zaoaliwe w Polsce w 2006 roku. Centrum Onkologii-Instytut, Warszawa 2006.
4. Spann SJ, Rozen P, Young GP et al.: Colorectal cancer: how big is the problem, why prevent it, and how might it present? In: Rozen P, Young GP, Levin B, Spann SJ, editors. Colorectal Cancer in Clinical Practice. London: Martin Dunitz Ltd 2002: 1-18.
5. Eriksen MT, Wibe A, Haffner J et al.: Prognostic group in 1,676 patients with T3 rectal treated without preoperative radiotherapy. Dis Colon Rectum 2007; 50: 156-67. (Pubitemid 46227211)
6. Bbenek M, Pudeko M, Cisarz K et al. Therapeutic results in low-rectal cancer patients treated with abdominosacral resection are similar to those obtained by means of anterior resection in mid-and upper-rectal cancer cases. Eur J Surg Oncol 2007; 33: 320-23. (Pubitemid 46488659)
7. Duffy MJ, van Dalen A, Haglund C et al: Tumor markers in colorectal cancers: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007; 43: 1348-60. (Pubitemid 46874070)
8. Compton C, Fenoglio-Preiser CM, Pettigrew N et al.: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Cancer Working Group. Cancer 2000; 88: 1739-57. (Pubitemid 30183160)
9. Konety BR, Getzenberg RH: Nuclear structural proteins as biomarkers of cancer. J Cell Biochem 1999; Suppl 32-33: 183-91. (Pubitemid 30041825)
10. Leman ES, Getzenberg RH: Nuclear structure as a source of cancer specific biomarkers. J Cell Biochem 2008; 104(6): 1988-93.
11. Brunagel G, Schoen RE, Getzenberg RH: Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps. J Cell Biochem 2004; 91: 365-74.
12. Miller TE, Beausang LA, Winchell LF et al.: Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 1992; 52: 422-27.
13. Leman ES, Schoen RE, Magheli A et al.: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clin Cancer Res 2008; 14(5): 1349-54. (Pubitemid 351413914)
14. Walgenbach-Brunagel G, Burger B, Leman ES et al.: The use of colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer. J Cell Biochem 2008; 104: 286-94.
15. Goslin R, O'Brien MJ, Steele G et al.: Correlation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med 1981; 71: 246-53. (Pubitemid 11000012)
16. Von Kleist S, Hesse Y, Kananeeh H: Comparative evaluation of 4 tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. Anticancer Res 1996; 16: 2325-31. (Pubitemid 26265586)